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Abstract
Background
Puumala hantavirus (PUUV) infected patients typically suffer from acute kidney injury (AKI).
Adipokines have inflammation modulating functions in acute diseases including AKI. We
examined plasma levels of three adipokines (resistin, leptin, and adiponectin) in acute
PUUV infection and their associations with disease severity.
Methods
This study included 79 patients hospitalized due to acute PUUV infection. Plasma resistin,
leptin, adiponectin, as well as IL-6 and CRP, were measured at the acute phase, recovery
phase and one year after hospitalization.
Results
Plasma resistin levels were significantly higher in the acute phase compared to the recovery
phase and one year after (median resistin 28 pg/mL (11–107) vs. 17 pg/mL (7–36) vs. 14
pg/mL (7–31), p<0.001). Maximum resistin concentration correlated with maximum plasma
creatinine levels (r = 0.63; p<0.001). The higher the amount of albuminuria in the urine dip-
stick test (0–1+, 2+ or 3+) at admission, the higher the median of maximum resistin (24.7 pg/
mL, 25.4 pg/mL and 39.6 pg/mL, respectively, p = 0.002). High resistin was also an indepen-
dent risk factor for severe AKI (creatinine�353.6μmol/L) (OR 1.08, 95% CI 1.02–1.14). Nei-
ther plasma leptin nor adiponectin level had any correlation with creatinine concentration or
the amount of albuminuria.
Conclusions
Plasma resistin independently associates with the severity of AKI in acute PUUV infection.
The association of resistin with the amount of albuminuria suggests that the level of plasma
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resistin is not only influenced by renal clearance but could have some role in the pathogene-
sis of AKI during PUUV infection.
Introduction
Puumala virus (PUUV) belongs to the family of hantaviruses and it is spread by the bank vole
(Myodes glareolus). In humans, PUUV causes an illness known as Nephropatia Epidemica
(NE) [1]. In Finland, thousands of serologically confirmed diagnoses are made annually and
the number of infected humans parallels the population of the bank vole. The disease is trans-
mitted by inhaling dust contaminated by PUUV-infected bank vole feces or urine [2].
The characteristic manifestation of PUUV infection is a mild form of hemorrhagic fever
with renal syndrome (HFRS) [3, 4]. Although many of the diagnosed patients need hospital
treatment, the majority of the infections are asymptomatic or cause only mild and transient
symptoms and thus remain undiagnosed [5]. In a Finnish cohort, 83% of hospital-treated
patients had acute kidney injury (AKI) [6]. This syndrome has a good prognosis: kidney func-
tion returns to normal in practically all patients by supportive therapy and the mortality is low,
around 0,1% [6, 7]. Several long-term nephrological, cardiovascular and endocrinological con-
sequences have, however, been described after PUUV infection [5].
Proteinuria and hematuria are typical urinary findings in the early phase of the infection.
Proteinuria is often of nephrotic range (>3g/day) and resolves rapidly. It might be a sign of
change in the barrier function of the glomerular vasculature [7]. The histological finding is
acute tubulointerstitial nephritis while glomerular changes are minimal [8]. Immunohisto-
chemical studies reveal abnormalities preferentially in the tubuli and peritubular areas, where
infiltrating cells consist of plasma cells, monocytes/macrophages, eosinophils and neutrophils.
At the same site, the expression of tumor necrosis factor (TNF)-α as well as endothelial adhe-
sion molecules intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule
(VCAM)-1 are seen, as a sign of endothelial cell activation [9].
Factors affecting the severity of PUUV infection remain mostly unclear, but host genetic
factors have an influence [10]. Inflammatory markers have been shown to increase during
acute PUUV infection, including plasma and urinary interleukins (ILs) IL-6, IL-1β, IL1
receptor antagonist, TNF-α, and soluble urokinase-type plasminogen activator receptor, as
well as plasma pentraxin-3 and urinary gelatinase-associated lipocalin (NGAL) [11–15]. Par-
ticularly urinary IL-6 and urinary NGAL [12, 16] have been found to associate with the
severity of AKI. The association of widely used C-reactive protein (CRP) with severe AKI in
PUUV infection is less clear [17] [12]. We have previously found that the amount of protein-
uria and hematuria in dipstick sample at the acute phase is associated with the severity of
AKI in NE patients [18, 19]. The peak of proteinuria seems to precede the most severe phase
of AKI [18].
Adipokines—also called adipocytokines—are bioactive molecules first found to be secreted
by adipose tissue, and to regulate appetite and energy metabolism. More recently, adipokines
have been discovered to be produced by many other cell types, particularly by inflammatory
cells, and to regulate inflammatory responses [20]. Interestingly, plasma resistin changes have
been reported in acute infections [21, 22] and AKI [23].
In the present study, our aim was to determine the adipokines adiponectin, leptin and resis-
tin in PUUV infection, and examine their associations with the severity of acute PUUV infec-
tion and the concomitant AKI.
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Materials and methods
The study cohort originally consisted of 86 consecutive patients with acute, serologically con-
firmed PUUV infection treated at the Tampere University Hospital in Finland, during Jan
2005-Nov 2014. Plasma samples for adipokine measurements were available in 79 patients and
these patients comprised the final study cohort. Detailed medical history was obtained and
physical examination was performed during the acute phase of the disease. All patients pro-
vided a written informed consent and the study was approved by the Ethics Committee of
Tampere University Hospital (R04180, R09206).
Acute PUUV infection was confirmed from a single serum sample by detecting the typical
granular staining pattern in immunofluorescence assay [24], and/or low avidity of IgG anti-
bodies to PUUV [25], and/or by detecting PUUV IgM antibodies by an ‘in-house’ enzyme-
linked immunosorbent assay (ELISA) based on a recombinant antigen [26].
Plasma samples for the measurement of resistin, leptin and adiponectin concentrations as
well as CRP and IL-6 levels were collected between 7:30–8:30 am, a median of 2 (1–5) times
during the acute phase. The highest or the lowest values (as appropriate) of the various vari-
ables measured during the hospital stay were designated as the maximum or minimum values.
The follow-up samples were obtained a median of 15 (range 7–21) days after discharge from
hospital in 74 patients, and at one year after hospitalization in 67 patients. Plasma resistin, lep-
tin, adiponectin, CRP and IL-6 concentrations were measured by an enzyme-linked immuno-
sorbent assay (ELISA) using reagents from R&D Systems Europe Ltd, Abingdon, UK (resistin,
leptin, adiponectin and CRP) and from eBioscience Inc, San Diego, CA, USA (IL-6). The
detection limit and interassay coefficient of variation were 15.6 pg/mL and 8.5% for resistin,
15.6 pg/mL and 5.3% for leptin, 15.6 pg/mL and 6.0% for adiponectin, 3.9 pg/mL and 5.7% for
CRP, and 0.39 pg/mL and 4.8% for IL-6. For adiponectin, the test detects total adiponectin.
Plasma creatinine was measured daily during hospitalization, median 5 (2–13) measure-
ments per patient, by a Cobas Integra (F. Hoffman- La Roche Ltd., Basel, Switzerland). A urine
dipstick test was performed on admission to hospital. The urine dipstick analysis was per-
formed by automated tests based on refractometry (Siemens Clinitec Atlas or Advantus). The
sensitivity of these semi-quantitative dipstick tests to urine albumin (1+) ranges 0.15–0.3 g/l.
The dipstick result 2+ indicates >1 g/l albumin, and the result 3+>3 g/l albumin. Assay for
hematuria detects heme pseudoperoxidase activity and therefore it detects red cell casts and
dysmorphic red cells also. The sensitivity of the assay is about 10 x 106 cells/L (about 3–5 cells
by high power field).
Severe AKI was defined as maximum plasma creatinine level�353.6 μmol/L during hospi-
talization (stage 3, according to KDIGO definition) [22]. The amount of hourly urine output
was not recorded. Here, shock is defined by a fall in systolic blood pressure under 90 mmHg
with clinical symptoms of shock. Body mass index (BMI) was calculated as the ratio of weight
(kg) to squared height (m2).
Statistical analyses
The data is presented as medians and ranges for continuous variables and numbers and per-
centages for categorical variables. Groups were compared using the Mann–Whitney U test or
the Kruskal-Wallis test, as appropriate. Correlations were calculated by the Spearman rank
correlation test. Related samples were compared using the Wilcoxon signed rank test or the
Friedman test, as appropriate. A receiver operating charasteristic (ROC) curves were drawn in
order to evaluate which of the maximum levels of various inflammatory markers could act as
the best indicator of severe AKI (plasma creatinine�353.6 μmol/L). A logistic regression anal-
ysis was performed with age, sex, BMI, dipstick-albuminuria class (0/1+,2+ and 3+) and
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maximum plasma resistin level as independent factors to examine the association of these fac-
tors with severe AKI. Adjusted odds ratios (OR) and their 95% confidence intervals (95% CI)
are given. The goodness of fit was assessed with Hosmer Lemeshow statistic. All tests were
two-sided, and p-values <0.05 were considered statistically significant. The SPSS statistical
software package (IBM SPSS Statistics version 23.0 Armonk, NY, USA) was used for all
analyses.
Results
The clinical characteristics and laboratory findings of the patients are listed in Table 1. The
median length of hospital stay was 6 days. The median age was 41 years (range 21–74) and 48
(61%) of the patients were males. The following diagnoses had been made before the acute
PUUV infection in 24 (30%) patients: hypertension (n = 7), asthma/chronic obstructive pul-
monary disease (n = 4), gastritis/reflux disease (n = 4), rheumatoid arthritis (n = 3), coronary
artery disease (n = 2), type 2 diabetes (n = 2), type 1 diabetes (n = 1), and transient ischemic
attack (n = 1). Some of the patients had more than one disease, but none had a known kidney
disease or chronic renal insufficiency.
The elevation of plasma creatinine level above 100 μmol/L was detected in 56 (70%)
patients. Severe AKI (creatinine�353.6 μmol/L) occurred in 25 (32%) patients. One patient
needed transient dialysis treatment and two patients suffered from a clinical shock on admis-
sion to hospital. All of the patients recovered. The median of the maximum plasma creatinine
at the acute phase was 186 μmol/L (range 51–1499) (Table 1). At the recovery phase (15 days
after hospitalization) and one year after the acute infection, the median of creatinine was
78 μmol/L (range 55–184) and 71 μmol/L (range 53–123) respectively.
The changes in plasma adipokine, IL-6 and CRP levels in the acute phase of PUUV infec-
tion, compared to the recovery phase and one year after hospitalization, are presented in
Table 2. and Fig 1. The median time to the first adipokine measurement from the onset of
fever was 7 days (range 3–14). The resistin levels (Fig 1A) were significantly higher and leptin
Table 1. Clinical and laboratory findings in 79 patients hospitalized due to acute Puumala hantavirus infection.
Finding Median Range
Age (years) 41 21–74
Body mass index, n = 72 (kg/m2) 26 18–37
Duration of fever (days) 8 4–15
Length of hospital stay (days) 6 2–14
Systolic blood pressure on admission (mmHg) 126 72–182
Change in body weight during hospital stay (kg) 2 0–11
Plasma creatinine max (μmol/L) 186 51–1499
Hematocrit max 0.44 0.33–0.60
Platelets min (x109/L) 52 5–150
Plasma sodium min (mmol/L) 130 109–139
Plasma potassium max (mmol/L) 4.2 3.3–5.3
Plasma albumin min (g/L) 25 18–34
Leukocytes max (x109/L) 10.8 4.2–45.0
IL-6 max (ρg/mL) 11.8 1.6–66.6
CRP max (ρg/mL) 57 8–199
Min, minimum value during hospital stay; max, maximum value during hospital stay; IL-6, Interleukin-6; CRP, C-
reactive protein
https://doi.org/10.1371/journal.pone.0208017.t001
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levels (Fig 1B) significantly lower in the acute phase, compared to those measured in the recov-
ery phase or one year after the acute illness. There was also a slight but statistically significant
decrease in adiponectin level in the acute phase compared to the recovery phase or one year
after the acute illness (Fig 1C).
The correlations of maximum plasma resistin concentration, minimum plasma adiponectin
and minimum plasma leptin with clinical and laboratory variables in the acute phase of PUUV
infection are shown in Table 3. The high resistin level correlated with higher maximum plasma
creatinine concentration. The median of maximum resistin was significantly higher in patients
with creatinine level >100 μmol/L compared to those with maximum creatinine� 100 μmol/
L (resistin 32 ρg/mL, range 11–107 vs. 21 ρg/mL, range 11–42, p<0.001). The maximum resis-
tin values also correlated with many other variables reflecting disease severity (Table 3). Inter-
estingly, the highest measured resistin value of this cohort (107 pg/mL) was detected in one of
the two patients with a clinical shock. The changes in the other two adipokines, minimum adi-
ponectin and minimum leptin didn’t have any clear correlations with the clinical disease sever-
ity markers in PUUV infection (Table 3).
The maximum plasma creatinine level measured during the hospital stay, didn’t have any
correlation with BMI (r = 0.145;p = 0.223). The minimum plasma leptin concentration had a
weak correlation with BMI (r = 0.350; p = 0.003) but not with maximum creatinine values
(Table 3).
Proteinuria on hospital admission (defined as urine albumin dipstick test�2+) was
detected in 54 (68%) patients. Hematuria (�2+ in urine dipstick test) was detected in 34 (43%)
of the patients. When analyzing the amount of proteinuria categorized by dipstick albuminuria
0/1+, 2+ or 3+ at the acute phase, the maximum resistin level was significantly higher in
patients with albuminuria 3+ than in patients with 0/1+ or 2+ albuminuria (Table 4). The
other adipokines studied were not associated with dipstick-albuminuria. When combining
albuminuria and hematuria findings in the urine dipstick test (0–2+, 3–4+ or 5–6+), the higher
the combined positive result, the higher was the maximum plasma resistin concentration
(Table 4).
We generated receiver operating curves (ROC) for the maximum plasma resistin, IL-6 and
CRP levels, as well as for the maximum leukocyte count, in the acute phase to discriminate
upcoming severe AKI (creatinine�353.6 μmol/L) from non-severe AKI (Fig 2). Resistin was a
stronger discriminator with area under ROC curve (AUROC) of 0.82 (95%CI 0.70–0.91,
p<0.001) when compared with leukocyte count (AUROC 0.74, 95% CI 0.62–0.87; p = 0.001).
IL-6 or CRP did not discriminate severe AKI from non-severe AKI (AUROC 0.55, 95% CI
0.40–0.70; p = 0.493 and AUROC 0.39, 95% CI 0.26–0.51; p = 0.105, respectively).
Table 2. The levels of plasma adipokines (resistin, leptin, adiponectin), and other markers of inflammation (leukocytes, plasma IL-6, CRP) in the acute phase of
Puumala hantavirus infection compared to the recovery phase and one year after the infection.
Acute phase� (n = 79) Recovery phase (n = 74) After 1 year (n = 67) p-value
median range median range median range
Resistin (ρg/mL) 28 11–107 17 7–36 14 7–31 <0.001
Leptin (ρg/mL) 5.3 1.2–48.4 12.2 1.6–68.7 12.1 1.8–84.0 <0.001
Adiponectin (ρg/mL) 3.76 0.23–10.66 4.07 0.62–10.25 4.36 0.80–13.49 <0.001
Leukocytes (x109/L) 10.8 4.2–44.4 7.6 3.7–14.5 6.7 3.7–11.4 <0.001
IL-6 (ρg/mL) 11.8 1.7–66.6 1.2 0.4–12.5 0.9 0.4–15.9 <0.001
CRP (ρg/mL) 57.3 8.4–198.5 1.7 0.2–36.0 1.3 0.1–13.2 <0.001
IL-6, interleukin-6; CRP, C-reactive protein. P-value stands for the differences between the three phases.
�Acute phase values are maximum (resistin, leukocytes, IL-6, CRP) or minimum (leptin, adiponectin)
https://doi.org/10.1371/journal.pone.0208017.t002
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We performed a logistic regression analysis to evaluate the associations of age, gender,
BMI, dipstick albuminuria and plasma resistin level with severe AKI (Table 5). In a univariate
model, male gender, dipstick albuminuria of 3+, and maximum resistin level were all associ-
ated with severe AKI. In the multivariable analysis only male gender and maximum plasma
resistin level were found to be independent risk factors for severe AKI.
Discussion
The present study shows that plasma resistin concentrations are elevated in the acute phase of
PUUV hantavirus infection. High resistin levels correlated with the severity of AKI, as well as
with several other markers reflecting the severity of the disease. High plasma resistin levels
during the acute infection also associated with pronounced albuminuria and hematuria
detected with urine dipstick test at hospital admission. Plasma resistin showed an independent
influence on severe AKI.
Resistin was first described in 2001 when it was found to be produced by adipose tissue and
promote insulin resistance in mice [27]. Further studies showed that in humans, resistin is
mainly produced by leukocytes, especially macrophages, and its contribution to the develop-
ment of insulin resistance remains unclear [28, 29]. The role of resistin as an inflammatory fac-
tor started to be unraveled by the early finding that injection of bacterial lipopolysaccharide
(LPS) into healthy volunteers caused a rise in circulating resistin levels [30]. Specific receptors
for resistin have not been identified, but it belongs to the endogenous ligands of the inflamma-
tion triggering toll-like receptor 4 (TLR-4) [31]. Accordingly, resistin is associated with an
array of inflammatory diseases including sepsis, inflammatory bowel disease, arthritis and
astma [32, 33]. We have previously found resistin as a contributing factor and biomarker
involved in osteoarthritis [34], rheumatoid arthritis [35], inflammatory lung diseases [36, 37]
and ischemia-reperfusion syndrome associated with cardiac surgery [38]. Interestingly, resistin
seems also to be produced by tumors / tumor associated macrophages. For instance, resistin
was recently reported as a predictive factor for the recurrence and long-term prognosis in
renal cell cancer [39]. Furthermore, plasma resistin levels have been found to be significantly
higher in patients with septic shock and AKI, when compared with patients with septic shock
without AKI, and it was found to modulate the inflammatory response in those patients [23].
Fig 1. Plasma resistin (A), leptin (B), and adiponectin (C) levels during acute Puumala hantavirus (PUUV)
infection, in the recovery phase, and one year after the hospitalization. Median (thick line inside box), 25th-75th
percentiles (box), range (whiskers), and outliers (�).
https://doi.org/10.1371/journal.pone.0208017.g001
Table 3. Correlations of plasma resistin concentration with clinical and laboratory markers of disease severity in acute Puumala hantavirus infection.
Resistin maximum, r p-value Adiponectin minimum, r p-value Leptin minimum, r p-value
Duration of hospital stay 0.507 <0.001 0.004 0.970 0.142 0.213
Systolic blood pressure on admission -0.257 0.022 -0.240 0.033 -0.103 0.368
Change in body weight during hospital stay 0.433 <0.001 -0.017 0.888 0.002 0.988
Creatinine max 0.633 <0.001 0.029 0.802 -0.044 0.700
Platelets min -0.254 0.024 -0.085 0.456 0.106 0.352
Sodium min -0.368 0.001 -0.015 0.895 0.241 0.032
Potassium max 0.369 0.001 -0.004 0.971 0.038 0.742
Leukocytes max 0.520 <0.001 0.060 0.600 -0.078 0.495
IL-6 max 0.329 0.003 -0.270 0.016 -0.160 0.160
CRP max -0.071 0.536 -0.457 <0.001 -0.034 0.763
max, maximum; min, minimum; CRP,C-reactive protein; IL-6, interleukin-6
https://doi.org/10.1371/journal.pone.0208017.t003
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There are a few studies investigating the significance of resistin in other acute virus infec-
tions. Plasma resistin was elevated in the early phase of acute Dengue fever, but associations
with kidney function or other disease severity markers were not reported [22]. In patients with
Crimean-Congo hemorrhagic fever, caused by tick-borne virus, plasma resistin was elevated
and higher concentrations associated with severe disease, defined by the manifestations of
bleeding. Resistin had a negative correlation with platelet count, but it did not have a correla-
tion with plasma creatinine. The kidney function of these patients was reported to be almost
normal and AKI was not addressed [40].
Table 4. Plasma resistin levels in different categories of urine dipstick albuminuria and hematuria in 79 patients
with Puumala hantavirus infection.
Urine dipstick albumin Resistin max
median (pg/mL)
range
0–1+ (n = 25) 24.7 11.6–90.7
2+ (n = 24) 25.4 11.9–80.4 p = 0.002
3+ (n = 30) 39.6 11.1–107.3
Urine dipstick albumin+erythrocytes
0–2+ (n = 26) 22.2 11.6–90.7
3–4+ (n = 35) 27.1 11.1–80.4 p<0.001
5–6+ (n = 18) 42.7 16.8–107.3
p-value stands for the differences between the three groups
https://doi.org/10.1371/journal.pone.0208017.t004
Fig 2. Receiver operating characteristic (ROC) curves for plasma resistin and different plasma inflammatory
markers (maximum C-reactive protein, maximum interleukin-6, and maximum leukocyte count) in predicting
severe acute kidney injury (plasma creatinine�353.6 μmol/L) during acute Puumala hantavirus infection.
https://doi.org/10.1371/journal.pone.0208017.g002
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The plasma resistin elevation in PUUV infection could be a sign of inflammation as previ-
ously shown in sepsis [21]. Plasma resistin is elevated in patients with septic shock [41, 42]. In
the present study, only two patients suffered from clinical shock, one of them having the high-
est plasma resistin concentration of this cohort. Furthermore, high resistin level correlated
with low systolic blood pressure at admission. The clinical shock syndrome in PUUV infection
is related to an increased vascular permeability, which probably has a role also in the pathogen-
esis of the nephrotic-range proteinuria [7].
In adult intensive care unit (ICU) patients, resistin was superior to CRP in distinguishing
sepsis from systemic inflammatory response (SIRS) due to trauma without infection, and the
level of resistin was significantly higher in sepsis compared to trauma related SIRS [43]. In ICU
patients, high resistin was shown to associate with worse long-time-survival in non-septic
patients, maybe as a sign of considerable harm of excessive inflammatory response [44]. We
have previously reported that plasma CRP poorly correlates with disease severity in PUUV infec-
tion compared to plasma IL-6 [12]. This finding was consolidated by the present study, where
the rise in CRP did not associate with severe AKI and the ROC curves didn’t show any diagnos-
tic ability of CRP to find severe AKI. In the ROC curves maximum plasma resistin level had the
best diagnostic accurancy to indicate severe AKI compared to leukocytes, IL-6 and CRP.
Many markers of inflammation are altered during acute PUUV infection, but not much is
known about their relationship with proteinuria, which in turn seems to have a clear associa-
tion with disease severity [18]. Increased capillary leakage seems to contribute to the amount
of proteinuria during acute PUUV infection [18, 45], and some inflammation markers may
have a more pronounced effect on this than others. Resistin has been previously related to vas-
cular permeability and endothelial activation. In emergency department patients with sepsis,
resistin and NGAL correlated with the expression of the endothelial cell adhesion molecules
(VCAM-1, ICAM-1) [42] and were associated with septic shock, but not with mortality [41].
Any possible association with AKI was not discussed.
Plasma levels of adiponectin did not show any association with maximum creatinine values
or albuminuria in hospital-treated patients in the present study. Low plasma adiponectin had,
however, negative correlation to inflammatory markers CRP and IL-6. Adiponectin is a
Table 5. Multivariate logistic regression analysis of risk factors for severe AKI (plasma creatinine�353.6 μmol/L) among 79 hospitalized patients with acute Puu-
mala hantavirus infection.
Univariate Multivariable
No severe AKI
n = 54
Severe AKI
n = 25
OR 95% CI OR 95% CI
Median (range) Median (range)
Age (years) 42 (22−67) 39 (21−74) 0.99 0.96−1.03 1.00 0.95−1.06
Sex (n)
Female 28 3 1 1
Male 26 22 7.90 2.11−29.54 6.73 1.16−38.90
BMI (kg/m2) n = 72 25.8 (18.5−37.0) 26.2 (22.6−32.3) 1.04 0.91−1.18 1.00 0.81−1.23
Albumin dipstick (n)
0–1+ 22 3 1 1
2+ 20 4 1.47 0.29−7.37 0.81 0.10−6.70
3+ 12 18 11.00 2.69−45.06 4.61 0.76−28.08
Resistin max (ρg/mL) 25.0 (11.6−52.6) 45.0 (11.0−107.3) 1.10 1.05−1.154 1.08 1.02−1.14
Max = maximum, min = minimum, IL-6 = interleukin-6, CRP = C-reactive protein.
Multivariable analysis Hosmer—Lemeshow test p = 0.591
https://doi.org/10.1371/journal.pone.0208017.t005
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multifunctional cytokine with mainly anti-inflammatory properties [20]. Among adipokines,
adiponectin is the most abundant in human serum. Elevated adiponectin concentrations are
seen in many inflammatory diseases, such as rheumatoid arthritis, systemic lupus erythemato-
sus, and inflammatory bowel disease, as well as in chronic kidney disease (CKD) [20]. Adipo-
nectin has functions protective against obesity-related diseases but its concentration is
decreased in obesity. The view of a possible role of adiponectin in AKI is mainly based on ani-
mal studies [46]. A protective effect of adiponectin has been shown in a murine model of ische-
mia-reperfusion -induced AKI [47]. If adiponectin has any protective effect on the
development of AKI in humans, remains unclear.
Leptin deficient mice are susceptible to severe AKI caused by lipopolysaccharide induced
endotoxic shock [48]. In the present study, leptin levels were decreased at the acute phase of
PUUV infection, but even after adjustment by BMI, low leptin level did not correlate with the
severity of AKI. When plasma leptin levels were compared between CKD patients on hemodi-
alysis, patients with AKI, and healthy subjects, the patients with AKI were shown to have simi-
lar leptin levels as healthy subjects, while the level was clearly elevated in hemodialysis patients
[49]. After kidney transplantation, the level of plasma leptin is shown to decline already during
the first day [50]. Although kidneys are considered as the main site of leptin metabolism, the
alterations of leptin level are possibly influenced by many coexisting factors affecting both its
synthesis and degradation [49]. Circulating leptin level is highly correlated with fat mass and
leptin concentrations have been reported to decrease in healthy subjects following fasting [51].
Anorexia, nausea and abdominal pain, and associated reduced food intake, frequently reported
symptoms in NE, could partly explain low acute-phase leptin levels in the present study. It
can’t be excluded, however, that low leptin at the acute phase of PUUV infection may contrib-
ute to the development of AKI.
There are scarce previous data about adipokine levels in patients with AKI. It is possible that
the rise in plasma resistin level reflects accumulation of that particular adipokine during reduced
glomerular filtration rate (GFR), since plasma resistin concentrations have been found to be ele-
vated in uremia [52]. The molecular weight of resistin is relatively low 12,5 kDa compared to lep-
tin 16 kDa and albumin 66 kDa. The molecular weight of adiponectin different multimers are
180–360 kDa. We believe that decreased GFR but also an increased synthesis of resistin can influ-
ence the elevation of plasma resistin level. In the present study, resistin had strong association
with proteinuria and hematuria. In the multivariate analysis high resistin level remained (along
with male gender) as an independent risk factor while the high amount of dipstick albuminuria (3
+) did not. To summarize, the observed rise in plasma resistin level may not be explained by mere
accumulation, but also increased synthesis, and thus resistin might have an independent influence
on the development of AKI. As a limitation, we were not able to determine the point of time after
the onset of fever when resistin peaks, because of varying delay of patient admission. The time
course between resistin peak and the most severe AKI phase remains to be investigated.
In conclusion, plasma resistin concentration is elevated in acute PUUV hantavirus infection
and it declines early during the recovery phase. Plasma resistin level is related to the severity of
AKI, as well as to the amount of proteinuria and hematuria. An increased plasma resistin con-
centration was found to be an independent risk factor for severe AKI in PUUV infected patients
also when adjusted to dipstick albuminuria. Further studies are needed to understand the role
of resistin as an AKI biomarker or possible treatment target in patients with PUUV infection.
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